These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention). Toso A; Leoncini M; Maioli M; Tropeano F; Di Vincenzo E; Villani S; Bellandi F JACC Cardiovasc Interv; 2014 Dec; 7(12):1421-9. PubMed ID: 25523533 [TBL] [Abstract][Full Text] [Related]
24. Designing clinical trials in acute kidney injury. Molitoris BA; Okusa MD; Palevsky PM; Kimmel PL; Star RA Clin J Am Soc Nephrol; 2012 May; 7(5):842-3. PubMed ID: 22442185 [No Abstract] [Full Text] [Related]
25. Did KDIGO guidelines on acute kidney injury improve patient outcome? Lameire N; Vanmassenhove J; Lewington A Intensive Care Med; 2017 Jun; 43(6):921-923. PubMed ID: 28352976 [No Abstract] [Full Text] [Related]
26. [Acute kidney failure: its diagnosis, the choice of the method of therapy, prognosis and outcome]. Nikolaev AIu; Milovanov IuS Ter Arkh; 1997; 69(6):68-70. PubMed ID: 9297282 [No Abstract] [Full Text] [Related]
28. [Important to investigate the cause of acute kidney injury. Treatment should aim to limit the damage and prevent progression]. Hertzberg D; Rydén L; Sartipy U; Holzmann M Lakartidningen; 2016 May; 113():. PubMed ID: 27138121 [TBL] [Abstract][Full Text] [Related]
29. Chronic on acute renal failure: long-term implications of severe acute kidney injury. Waikar SS; Winkelmayer WC JAMA; 2009 Sep; 302(11):1227-9. PubMed ID: 19755705 [No Abstract] [Full Text] [Related]
30. Biomarkers for AKI improve clinical practice: no. Ostermann M; Joannidis M Intensive Care Med; 2015 Apr; 41(4):618-22. PubMed ID: 25387818 [No Abstract] [Full Text] [Related]
31. Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury. Westhoff JH; Seibert FS; Waldherr S; Bauer F; Tönshoff B; Fichtner A; Westhoff TH Eur J Pediatr; 2017 Jun; 176(6):745-755. PubMed ID: 28409285 [TBL] [Abstract][Full Text] [Related]
32. Risk factors for the prognosis of acute kidney injury under the Acute Kidney Injury Network definition: a retrospective, multicenter study in critically ill patients. Zhou J; Yang L; Zhang K; Liu Y; Fu P Nephrology (Carlton); 2012 May; 17(4):330-7. PubMed ID: 22309622 [TBL] [Abstract][Full Text] [Related]
33. How to improve the care of patients with acute kidney injury. Bellomo R; Vaara ST; Kellum JA Intensive Care Med; 2017 Jun; 43(6):727-729. PubMed ID: 28600756 [No Abstract] [Full Text] [Related]
34. Early diagnosis of acute kidney injury: the promise of novel biomarkers. Soni SS; Ronco C; Katz N; Cruz DN Blood Purif; 2009; 28(3):165-74. PubMed ID: 19590184 [TBL] [Abstract][Full Text] [Related]
35. Application of new acute kidney injury biomarkers in human randomized controlled trials. Parikh CR; Moledina DG; Coca SG; Thiessen-Philbrook HR; Garg AX Kidney Int; 2016 Jun; 89(6):1372-9. PubMed ID: 27165835 [TBL] [Abstract][Full Text] [Related]
36. Nationwide epidemiology and prognosis of dialysis-requiring acute kidney injury (NEP-AKI-D) study: Design and methods. Shiao CC; Wu PC; Wu VC; Lin JH; Pan HC; Yang YF; Lai TS; Huang TM; Wu CH; Yang WS; Wu CJ; Kao CC; Sun CY; Huang CT; Lee KH; Lin CY; Chen TC; Hu FC; Liou HH; Lu KC; Chien KL; Wang JJ; Kan WC; Kuo FC; Lin HY; Chen CM; You ZH; Tsai JP; Weng CJ; Chen HY; Chang CF; Hsu WD; Wu MS; Huang CC; Wu KD; Nephrology (Carlton); 2016 Sep; 21(9):758-64. PubMed ID: 27546777 [TBL] [Abstract][Full Text] [Related]